Table III.1: Reported Laws, Regulations, or Policies Related to Drug Compounding, by Reporting State, as of January 1, 2016
State Laws, regulations, or policies specific to the practice of drug compounding Laws enacted, or regulations or policies adopted, related to drug compounding in response to the federal Drug Quality and Security Act (Pub. L. No. 113-54) Additional legislation, regulations, or policies related to drug compounding under consideration Laws, regulations, or policies specific to drug compounding by physicians or other nonpharmacist health care practitioners Pending or proposed laws, regulations, or policies specific to drug compounding by physicians or other nonpharmacist health care practitioners Laws, regulations, or policies specific to Food and Drug Administration (FDA) registered outsourcing facilities Pending or proposed legislation specific to FDA-registered outsourcing facilities
Alabama Yes No Yes No No No Yes
Arizona Yes No Yes Don't know No No No
Arkansas Yes Yes No No Don't know Yes No
California Yes Yes Yes No Yes No Yes
Colorado Yes Yes Yes Yes No No No
Connecticut Yes Yes Don't know Don't know Don't know No No
Delaware Yes Yes Yes Yes No Yes Yes
District of Columbia Yes No Yes No No No No
Florida Yes Yes Yes No No No No
Georgia Yes Yes Yes No No No Yes
Guam Yes No No Don't know Don't know Don't know Don't know
Hawaii Yes No No Don't know Don't know No No
Idaho Yes Yes Yes No No Yes No
Illinois Yes No Yes No - - -
Iowa Yes Yes Yes No Don't know No Yes
Kansas Yes No Yes No No No Yes
Kentucky Yes No Yes No No No Yes
Louisiana Yes Yes Yes Don't know Don't know No No
Maine Yes No Don't know Don't know Don't know No No
Maryland Yes Yes - - - - -
Massachusetts Yes Yes Yes Don't know Don't know Yes No
Michigan Yes No Don't know Don't know Don't know Yes Don't know
Minnesota Yes Yes No Yes No Yes No
Mississippi Yes Yes Yes Don't know Don't know Yes No
Missouri Yes No Yes Don't know No No Yes
Montana Yes No Don't know No Don't know No No
Nebraska Yes Yes Don't know Yes Don't know No No
Nevada Yes No Yes Don't know Don't know No Yes
New Hampshire Yes Yes No Yes No No No
New Jersey Yes No Don't know Don't know Don't know Don't know Don't know
New Mexico Yes Yes No No No Yes Yes
New York No Yes No No No Yes No
North Carolina Yes Yes No Don't know Yes Yes No
North Dakota Yes Yes Yes Yes No Yes No
Ohio Yes Yes No Yes No Yes No
Oklahoma Yes No No Don't know Don't know Yes No
Oregon Yes Yes Yes Don't know Don't know Yes No
Pennsylvania No No Yes No No Don't know Don't know
Rhode Island Yes No No No Don't know No Yes
South Carolina Yes No Yes No No No No
South Dakota Yes No Yes No No No Yes
Tennessee Yes Yes - No Don't know Yes Don't know
Texas Yes No No No No Don't know Don't know
Utah Yes Yes Yes Yes No No No
Vermont Yes No Yes No No No No
Virginia Yes Yes Yes Yes Yes Yes No
Washington Yes No Yes Don't know Don't know No No
West Virginia Yes Yes Yes Don't know Don't know Yes Yes
Wisconsin Yes No Yes No Don't know No Don't know
Wyoming Yes No Yes No Don't know No No

Source: GAO survey of state pharmacy regulatory bodies, survey question 12. | GAO-17-363SP
Note: GAO surveyed the state pharmacy regulatory bodies in the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands, and all but 4 completed the survey.